This Week in PLOS

In PLOS Genetics, American researchers used genomic approaches to characterize bipolar disorder in individuals belonging to a large, well-documented Amish pedigree. Along with SNP and microsatellite data on 388 members of an Amish family, the team performed whole-genome sequencing on 50 of the study participants — data used for subsequent linkage and association analyses.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.